Rare Disease Advocates

501C3 Nonprofit Organization Information

  •   Get Unlimited Access to 990 Returns
  •   Get Unlimited Access to Financial Data
  •   Download in PDF format
Name & address Rare Disease Advocates
Po Box 65731
Los Angeles, CA 90065-0731
EIN / Tax ID99-3548319
Classification501(c)(3)Charitable Organization
DeductibilityContributions are deductible

Rare Disease Advocates is a 501(c)(3) charitable nonprofit in Los Angeles, California (EIN 99-3548319). It has been tax-exempt since September 2024, and contributions to it are tax-deductible. Its Form 990-EZ for tax year 2024 reports total revenue of $123,833 and net assets of $7,225. TaxExemptWorld has Form 990s on file for 1 tax year (2024). The IRS classifies its activity as Public Health Program (NTEE E70). It is one of 26,710 nonprofits in Los Angeles, CA.

LatestForm 990-EZ summary · Tax year 2024

Form 990-EZ · Tax period ending Dec 2024 · Filed Oct 4, 2025 · From the IRS e-file data

Total revenue$123,833
Total expenses$116,608
Net assets, end of year$7,225
Spent on programs94%of total expenses

Where the money comes from

Contributions & grants 3%Program services 97%

Where the money goes

Programs 94%Other expenses 6%

Dollar amounts for every revenue and expense line are in the full 990 report.

At a glance

Exempt status501(c)(3)
Websitehttps://rarediseaseadvocates.org

Mission (as filed): AT RARE DISEASE ADVOCATES ORGANIZATION, OUR MISSION IS TO EMPOWER AND UPLIFT INDIVIDUALS IMPACTED BY RARE DISEASES. RARE DISEASE ADVOCATES IS A NON-PROFIT ORGANIZATION DEDICATED TO RAISING PROVIDER AWARENESS, PROVIDING PATIENT SUPPORT, AND ADVOCATING FOR BETTER RESOURCES AND RESEARCH FOR THOSE LIVING WITH RARE MEDICAL CONDITIONS.WE SERVE HEALTH CARE PROVIDERS AROUND THE COUNTRY BUT PRIMARILY FOCUSING ON SOUTHERN CALIFORNIA BY CONDUCTING EDUCATIONAL SEMINARS AND PROVIDING FINANCIAL SUPPORT TO RARE DISEASE PATIENTS. THERE ARE OVER TEN THOUSAND RARE DISEASES. RARE DISEASES ARE ESTIMATED TO AFFECT MORE THAN THIRTY MILLION PEOPLE IN THE UNITED STATES. EACH DISEASE MAY BE RARE INDIVIDUALLY, BUT PEOPLE WITH RARE DISEASES OFTEN FACE SIMILAR CHALLENGES. THESE CHALLENGES MAY INCLUDE ACCESSING INFORMATION, GETTING A DIAGNOSIS, AND FINDING RESOURCES.OUR ORGANIZATION'S THREE PRIMARY OBJECTIVES:RAISE AWARENESS, PROVIDE SUPPORT AND ADVOCATE FOR CHANGE

Programs (as filed)

EDUCATIONAL CONFERENCE SERIES ON PNH AND MDS: FROM AUGUST TO NOVEMBER 2024, RARE DISEASE ADVOCATES LAUNCHED A SERIES OF EDUCATIONAL SEMINARSFOCUSED ON PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND MYELODYSPLASTIC SYNDROMES (MDS). EACHEVENT FEATURED A CLINICAL PRESENTATION LED BY A PHARMD AND MD TEAM, DELIVERED TO A TARGETED AUDIENCE OFHEALTHCARE PROFESSIONALS INCLUDING PHYSICIANS, FELLOWS, NURSE PRACTITIONERS, AND PHARMACISTS. THESESESSIONS EMPHASIZED DIAGNOSTIC CHALLENGES, DISEASE PROGRESSION, AND EMERGING TREATMENT STRATEGIES TOIMPROVE AWARENESS AND CLINICAL OUTCOMES FOR THESE RARE HEMATOLO…

Share of program spending
73%

EDUCATIONAL CONFERENCE SERIES ON MYELOFIBROSIS, AML, AND BPDCN: THE FINAL EDUCATIONAL EVENT IN DECEMBER 2024 FOCUSED ON MYELOFIBROSIS (MF), ACUTE MYELOID LEUKEMIA(AML), AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). LIKE PRIOR CONFERENCES, THE SESSION WAS PRESENTED BY A PHARMD AND MD TEAM TO A TARGETED AUDIENCE OF HEALTHCARE PROFESSIONALS INCLUDING PHYSICIANS, FELLOWS, NURSE PRACTITIONERS, AND PHARMACISTS. THE GOAL WAS TO PROVIDE EDUCATION ON THE LATEST TREATMENT STRATEGIES, IMPROVE DISEASE RECOGNITION, AND HIGHLIGHT PATIENT CARE CONSIDERATIONS SPECIFIC TO THESE RARE HEMATOLOGIC MA…

Share of program spending
18%

ORGANIZATIONAL INFRASTRUCTURE DEVELOPMENT: IN ITS FOUNDATIONAL YEAR, RARE DISEASE ADVOCATES FOCUSED ON ESTABLISHING THE INTERNAL INFRASTRUCTUREREQUIRED TO SUPPORT LONG-TERM, MISSION-ALIGNED PROGRAMMING. THIS INCLUDED DEVELOPING AND LAUNCHINGTHE ORGANIZATION'S OFFICIAL WEBSITE, SETTING UP A DONATION PORTAL AND NONPROFIT BANK ACCOUNT, AND INITIATING PARTNERSHIPS WITH SEVERAL PHARMACEUTICAL SPONSORS. THESE EFFORTS LAID A STRONG GROUNDWORK FOROPERATIONAL EFFICIENCY, DONOR ENGAGEMENT, AND STRATEGIC GROWTH IN THE RARE DISEASE ADVOCACY SPACE.

Share of program spending
9%

Officers & directors

1Ceo/Director
1 person listed on the return 0 with no reported pay
Names, titles, hours and pay for the person listed are in the full 990 report and data download.

Other information

Political campaign activityNo

Public charity (509(a)(2))

Prepared by TaxExemptWorld from IRS Form 990-EZ e-file data (object ID 202542779349200109). Not an official IRS form.

  • Executive officer name & phoneAvailable with membership or data download
  • TaxonomyPublic Health Program
  • Filing requirementForm 990 - (all other) or 990EZ return
  • AffiliationThis organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations).
  • Foundation typeNormally receives no more than one third of its support from gross investment income and unrelated business income and at the same time more than one third of its support from contributions, fees, and gross receipts related to exempt purposes
  • Tax period12/2024

Form 990s on file

990 Summary PDFs 1 year · built from the IRS e-file data
2024
Download everything for this organization All available information, plus 990 summaries for all 1 tax year.

In the full 990 report for Rare Disease Advocates

  • Names, titles, hours and pay for the officer or director listed
  • Every revenue source and expense line in dollars
  • Full balance sheet: assets, liabilities and net assets at the start and end of the year
  • Dollars spent on each program
  • Revenue and asset history by year
  • Form 990s for 1 tax year, 2024: 1 TaxExemptWorld summary

Largest nonprofits in Los Angeles, CA

Similar health care nonprofits in California

All 7,739 health care nonprofits in California